info icon

Autism

F5_AUTISM

autism: A disorder characterized by marked impairments in social interaction and communication accompanied by a pattern of repetitive, stereotyped behaviors and activities. Developmental delays in social interaction and language surface prior to age 3 years.

Suggest a new description

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 F84.0, F84.1, F84.5
  • Hospital discharge: ICD-9 2990
  • Cause of death: ICD-10 F84.0, F84.1, F84.5
  • Cause of death: ICD-9 2990

2 out of 7 registries used, show all original rules.

1122

4. Check minimum number of events

None

1122

5. Include endpoints

None

1122

6. Filter based on genotype QC (FinnGen only)

1061

Control definitions (FinnGen only)

Control exclude
F5_PSYCHDEV

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 1061 541 520
Unadjusted period prevalence (%) 0.21 0.19 0.24
Median age at first event (years) 24.95 27.19 22.62

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1122
Matched controls
11220
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F84.5
ICD-10 Finland
Asperger syndrome
6541.1
307.7
1007
15
F90.0
ICD-10 Finland
Disturbance of activity and attention
11.8
307.7
476
661
N06BA04
ATC
methylphenidate; oral
10.6
298.1
412
582
N05AX08
ATC
risperidone; systemic
11.2
253.0
310
369
N05AH04
ATC
quetiapine; oral
6.6
220.2
563
1481
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
5.9
180.5
463
1190
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
7.8
163.8
262
420
N05AX12
ATC
aripiprazole; systemic
7.9
163.6
260
414
N06AX12
ATC
bupropion; oral
6.2
153.6
323
682
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
8.5
146.3
210
296
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
7.2
146.1
251
432
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
401.6
144.5
142
*
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
11.4
142.4
158
159
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.9
139.6
431
1259
ZY010
NOMESCO Finland
Hospital outpatient
6.4
136.0
265
516
F29
ICD-10 Finland
Unspecified nonorganic psychosis
7.7
135.2
211
326
N05AH03
ATC
olanzapine; systemic
6.4
130.8
252
484
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
6.0
125.8
264
549
F84.0
ICD-10 Finland
Childhood autism
+∞
123.2
116
*
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
8.9
121.1
163
211
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
7.2
119.9
199
327
N06AX16
ATC
venlafaxine; oral
4.8
116.9
336
912
N06AB03
ATC
fluoxetine; oral
5.3
114.6
278
655
N06AB06
ATC
sertraline; oral
4.7
113.5
343
967
Z2445
NOMESCO Finland
Psychologist
6.2
111.0
215
412
N03AX09
ATC
lamotrigine; oral
6.2
102.7
196
369
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.4
96.2
303
871
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
8.9
95.5
126
158
N06BA12
ATC
lisdexamfetamine; oral
9.6
94.6
117
135
ZYC01
NOMESCO Finland
Remote contact by phone
6.0
93.1
184
357
N06AB10
ATC
escitalopram; oral
3.5
89.1
465
1876
Z2446
NOMESCO Finland
Social worker
5.1
89.1
216
502
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.7
88.7
392
1421
F83
ICD-10 Finland
Mixed specific developmental disorders
462.2
87.4
86
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
8.3
84.1
117
156
N05BA04
ATC
oxazepam; oral
3.6
81.7
376
1389
P29
ICPC
Psychological sympt/compl other
4.0
81.0
287
889
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.5
79.4
171
357
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.1
79.2
186
419
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
4.5
78.1
220
574
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
12.6
77.1
77
65
IGV01
NOMESCO Finland
Psychiatric network contact
9.9
75.8
90
98
P99
ICPC
Psychological disorders other
6.8
75.6
126
205
F34.1
ICD-10 Finland
Dysthymia
6.5
75.2
131
223
F93.89
ICD-10 Finland
Other childhood emotional disorders
8.1
74.0
104
140
N06AX26
ATC
vortioxetine; oral
4.2
73.7
231
652
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
5.0
72.3
171
386
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
5.2
71.4
161
349
F84.8
ICD-10 Finland
Other pervasive developmental disorders
+∞
70.6
67
*
N03AG01
ATC
valproic acid; systemic, rectal
5.5
69.7
147
300
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
5.1
65.4
151
333
SPAT1240
SPAT
Therapeutic discussion
3.3
64.8
319
1207
N06AX11
ATC
mirtazapine; oral
3.0
64.3
434
1967
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
19.6
59.9
47
25
N06AB04
ATC
citalopram; systemic
3.5
58.7
237
788
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.8
58.0
142
328
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
5.0
57.2
133
294
SPAT1307
SPAT
Psychosocial counselling and guidance
3.3
56.6
271
1000
F61.0
ICD-10 Finland
Mixed personality disorders
8.3
56.3
76
97
N05AB03
ATC
perphenazine; systemic, rectal
7.4
56.1
84
121
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
5.3
53.8
116
240
IGY99
NOMESCO Finland
Other psychiatric treatment contact
5.4
53.7
113
229
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
5.8
51.8
100
187
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
8.8
51.5
66
79
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
6.1
50.9
93
165
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
13.1
50.6
49
39
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
6.2
49.8
88
151
F99
ICD-10 Finland
Mental disorder, not otherwise specified
6.5
48.3
82
135
F40.1
ICD-10 Finland
Social phobias
4.1
47.9
142
379
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.4
47.1
126
311
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
11.3
47.1
50
46
N06AX21
ATC
duloxetine; oral
3.6
45.7
171
536
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
11.1
45.5
49
46
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
6.3
45.5
79
133
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.3
44.6
189
641
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
2.8
44.4
290
1256
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.2
43.6
125
325
XA800
NOMESCO Finland
Neuropsychological investigation
5.2
42.9
92
189
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.7
41.3
102
236
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
5.9
40.8
76
137
P01
ICPC
Feeling anxious/nervous/tense
2.4
40.0
399
2099
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.5
39.8
102
243
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.0
39.7
123
338
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
6.6
39.6
65
103
IBZ08
NOMESCO Finland
Gender identity assessment
12.2
38.7
39
33
F21
ICD-10 Finland
Schizotypal disorder
14.4
38.3
35
25
F80.2
ICD-10 Finland
Receptive language disorder
201.8
38.0
39
*
N06BA09
ATC
atomoxetine; oral
9.4
38.0
46
51
IGY02
NOMESCO Finland
Psychiatric monitoring contact
3.9
37.6
118
327
SPAT1389
SPAT
Visit based on need for special support
3.4
37.5
151
494
P03
ICPC
Feeling depressed
2.5
37.3
297
1403
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
10.3
37.3
42
42
N06AX22
ATC
agomelatine; oral
5.4
37.0
75
146
F82
ICD-10 Finland
Specific developmental disorder of motor function
196.5
37.0
38
*
ZY000
NOMESCO Finland
Hospital inpatient
6.4
36.5
62
102
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
10.3
36.4
41
41
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
11.5
36.4
38
34
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.0
36.0
81
173
ZYY01
NOMESCO Finland
Contact between professionals
10.9
35.9
39
37
F42.0
ICD-10 Finland
Predominantly obsessional thoughts or ruminations
8.5
35.3
46
56
IEV99
NOMESCO Finland
Other psychiatric network intervention
7.8
35.0
49
65
F60.9
ICD-10 Finland
Personality disorder, unspecified
7.3
35.0
52
74
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.0
34.9
105
282
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
6.2
34.5
60
101
P76
ICPC
Depressive disorder
3.0
34.5
176
661
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.9
34.3
63
112
N05AD01
ATC
haloperidol; systemic
8.0
34.2
47
61
F80.1
ICD-10 Finland
Expressive language disorder
180.5
33.9
35
*
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
9.1
33.8
42
48
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
+∞
33.5
32
*
N05AE04
ATC
ziprasidone; systemic
10.1
33.1
38
39
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
4.3
33.0
89
220
OAB43, ,
SPAT
0.4
33.0
174
3722
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
6.2
32.7
57
96
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
4.9
32.6
74
159
N05BA01
ATC
diazepam; systemic, rectal
3.2
32.5
142
487
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
5.9
32.3
59
104
F89
ICD-10 Finland
Unspecified disorder of psychological development
90.3
31.9
35
*
R62.0
ICD-10 Finland
Delayed milestone
9.1
31.7
39
44
Z07
ICPC
Education problem
5.5
31.5
63
121
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.2
31.4
86
215
F84.10
ICD-10 Finland
Autism in atypical age
+∞
31.4
30
*
SPAT1243
SPAT
Psychiatric/psychological examination
3.6
31.4
109
323
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
31.1
245
1142
F33.8
ICD-10 Finland
Other recurrent depressive disorders
8.3
30.9
41
51
F39
ICD-10 Finland
Unspecified mood [affective] disorder
4.6
30.8
75
171
N05AF03
ATC
chlorprothixene; systemic
6.1
30.6
54
92
P81
ICPC
Hyperkinetic disorder
5.5
30.6
61
117
Z3231
NOMESCO Finland
Registered nurse
2.2
30.4
339
1833
F41.8
ICD-10 Finland
Other specified anxiety disorders
3.6
30.2
106
316
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
4.1
30.2
87
226
F60.5
ICD-10 Finland
Anankastic personality disorder
7.5
29.8
43
59
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
10.6
29.0
32
31
F64.0
ICD-10 Finland
Transsexualism
10.6
29.0
32
31
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
5.5
29.0
57
108
F88
ICD-10 Finland
Other disorders of psychological development
106.2
28.8
31
*
SPAT1234
SPAT
Support of social functional capacity
4.9
28.6
65
140
N05AN01
ATC
lithium; oral
5.0
28.4
62
129
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
10.0
27.8
32
33
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
10.3
27.5
31
31
N06AB05
ATC
paroxetine; oral
3.9
27.3
83
224
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
38.9
27.2
34
9
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.9
27.2
137
508
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.4
27.2
71
171
IER01
NOMESCO Finland
Psychoeducation, group
7.1
26.9
41
60
IGP01
NOMESCO Finland
Psychiatric family contact
5.2
26.8
56
112
F31
ICD-10 Finland
Bipolar affective disorder
6.6
26.6
43
67
C07AA05
ATC
propranolol; systemic
2.2
26.5
284
1499
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
8.1
26.5
36
46
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
4.0
26.3
77
202
F32.1
ICD-10 Finland
Moderate depressive episode
2.7
26.2
153
613
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.6
26.2
91
269
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.3
26.1
107
352
SPAT1215
SPAT
Assessment of need for medical rehabilitation
4.2
26.0
71
177
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.5
25.7
180
789
N05BA06
ATC
lorazepam; systemic, sublingual
4.9
25.7
58
124
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
6.5
25.4
42
67
F84.11
ICD-10 Finland
Autism with atypical symptoms
+∞
25.1
24
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.8
25.0
136
525
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.8
25.0
57
123
F43.1
ICD-10 Finland
Post-traumatic stress disorder
3.5
24.8
90
274
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
92.2
24.8
27
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.2
24.7
257
1336
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
4.2
24.7
67
166
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
3.7
24.6
81
231
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
6.4
24.6
41
66
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
9.0
24.3
30
34
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.2
24.1
101
336
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
6.0
24.1
43
74
SPAT1310
SPAT
Counselling related to known health issue
1.9
24.0
429
2714
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
3.2
23.8
101
339
P74
ICPC
Anxiety disorder/anxiety state
2.7
23.7
136
540
N06AG02
ATC
moclobemide; oral
5.2
23.4
49
98
F50.8
ICD-10 Finland
Other eating disorders
8.5
23.2
30
36
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.0
23.1
106
372
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
5.4
23.1
46
88
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.2
22.7
93
305
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
7.9
22.6
31
40
Z72.8
ICD-10 Finland
Other problems related to lifestyle
7.6
22.6
32
43
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
4.2
22.3
61
152
ZXY49
NOMESCO Finland
Other health care provider
8.5
22.3
29
35
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
8.1
22.2
30
38
IAB03
NOMESCO Finland
Neuropsychiatric consultation
53.2
22.2
26
5
F33
ICD-10 Finland
Recurrent depressive disorder
4.0
22.0
64
167
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
5.5
22.0
43
81
N06AX03
ATC
mianserin; oral
5.0
21.9
48
100
R5599
NOMESCO Finland
Other rehabilitation service
5.0
21.9
48
100
P06
ICPC
Sleep disturbance
2.3
21.8
182
860
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
7.1
21.7
33
48
N05BE01
ATC
buspirone; oral
4.6
21.5
52
118
N05AH02
ATC
clozapine; systemic
4.5
21.3
53
123
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
9.2
21.3
26
29
SPAT1139
SPAT
Nutrition survey
5.0
21.2
46
95
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
6.3
21.2
36
59
SPAT1284
SPAT
Extensive health certificate
3.6
21.2
71
205
F60.8
ICD-10 Finland
Other specific personality disorders
8.6
21.1
27
32
F20.9
ICD-10 Finland
Schizophrenia, unspecified
4.9
20.9
47
100
G47.3
ICD-10 Finland
Sleep apnoea
2.3
20.9
170
794
N06AA04
ATC
clomipramine; systemic
7.5
20.9
30
41
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
5.7
20.5
38
68
SPAT1229
SPAT
Assessment of need for aid
4.9
20.5
45
94
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
5.3
20.4
41
79
N04AA02
ATC
biperiden; systemic
6.3
20.3
34
55
F50.9
ICD-10 Finland
Eating disorder, unspecified
4.4
20.1
51
120
Z3226
NOMESCO Finland
Physiotherapist
2.2
20.1
187
924
IEP99
NOMESCO Finland
Other psychiatric family intervention
6.1
20.0
35
59
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.3
19.7
40
78
N05AA02
ATC
levomepromazine; systemic
3.9
19.7
58
153
IEP03
NOMESCO Finland
Focused parental counselling
7.5
19.6
28
38
N03AX11
ATC
topiramate; oral
4.2
19.4
53
132
T82
ICPC
Obesity
3.5
19.1
69
209
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
19.0
203
1057
F32
ICD-10 Finland
Depressive episode
2.7
18.9
111
444
N03AE01
ATC
clonazepam; systemic
3.8
18.9
59
162
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
6.5
18.9
31
49
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
8.2
18.8
25
31
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.5
18.7
124
527
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
193.1
18.6
19
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.9
18.4
56
151
W78
ICPC
Pregnancy
0.4
18.4
82
2002
IGY02, ,
SPAT
5.1
18.4
39
79
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
19.7
18.2
27
14
F32.8
ICD-10 Finland
Other depressive episodes
4.1
18.2
50
125
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.3
18.2
71
226
N05BA12
ATC
alprazolam; oral
2.9
18.0
91
337
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.4
17.9
137
2672
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
4.7
17.9
42
93
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
5.5
17.7
34
63
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
37.4
17.6
22
6
F42.9
ICD-10 Finland
Obsessive-compulsive disorder, unspecified
5.6
17.5
33
60
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
24.5
17.4
24
10
F81.0
ICD-10 Finland
Specific reading disorder
21.3
17.3
25
12
AA400
NOMESCO Finland
Electroconvulsive therapy
6.7
17.1
27
41
F50.1
ICD-10 Finland
Atypical anorexia nervosa
6.0
17.0
30
51
IEY01
NOMESCO Finland
Psychoeducation, individual
5.3
16.8
34
66
F41.3
ICD-10 Finland
Other mixed anxiety disorders
3.6
16.8
56
161
A28
ICPC
Limited function/disability NOS
3.2
16.6
68
223
F84.12
ICD-10 Finland
Autism both in atypical age and with atypical symptoms
172.5
16.5
17
*
N06AX05
ATC
trazodone; oral
4.5
16.5
40
91
N05CF01
ATC
zopiclone; oral
2.0
16.2
198
1079
N05CF02
ATC
zolpidem; oral
2.2
16.2
142
681
SPAT1395
SPAT
Health check-up of persons outside student and working life
4.6
16.2
38
84
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
5.4
16.1
32
61
P85
ICPC
Mental retardation
18.8
16.0
24
13
R1250
NOMESCO Finland
Evaluation of functional capability
5.5
16.0
31
58
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
5.5
16.0
31
58
R5140
NOMESCO Finland
Monitoring the use of the aid
2.9
15.8
77
279
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
15.8
184
986
M35.7
ICD-10 Finland
Hypermobility syndrome
4.5
15.8
39
90
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
4.7
15.7
36
78
N06AB08
ATC
fluvoxamine; oral
6.1
15.6
27
45
N06AX17
ATC
milnacipran; oral
19.5
15.6
23
12
T05
ICPC
Feeding problem of adult
5.0
15.5
33
67
F50.0
ICD-10 Finland
Anorexia nervosa
4.7
15.5
36
79
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
4.1
15.3
42
105
Z29
ICPC
Social problem NOS
3.5
15.0
51
149
F32.01
ICD-10 Finland
Mild depressive episode with somatic syndrome
6.9
14.9
23
34
183
Kela drug reimbursment
Lamotrigin and topiramate
6.0
14.8
26
44
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
32.2
14.8
19
6
SPAT1051
SPAT
Guidance regarding sleep disorders
4.6
14.8
35
78
Z08
ICPC
Social welfare problem
5.4
14.7
29
55
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
+∞
14.6
14
*
ZXY60
NOMESCO Finland
2-person team, nurses
5.9
14.5
26
45
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.3
14.5
123
582
SPAT1260
SPAT
Consultation of another employee
2.0
14.4
189
1054
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.4
14.4
107
2139
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
10.6
14.3
27
26
N06AX18
ATC
reboxetine; oral
13.6
14.2
24
18
P79
ICPC
Phobia/compulsive disorder
5.2
14.2
29
57
M79.7
ICD-10 Finland
Fibromyalgia
3.7
14.1
44
121
N03AX16
ATC
[U] pregabalin
2.1
14.0
144
735
IHZ05, ,
SPAT
2.2
14.0
124
597
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.3
13.9
47
1329
N05BA09
ATC
clobazam; oral
6.1
13.9
24
40
K59.09
ICD-10 Finland
Constipation, unspecified
3.2
13.9
55
177
P22
ICPC
Child behaviour symptom/complaint
4.0
13.9
40
104
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.9
13.7
65
232
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.3
13.7
107
488
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.6
13.7
82
331
N05AX15
ATC
cariprazine; oral
6.6
13.7
22
34
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
4.7
13.6
31
67
P98
ICPC
Psychosis NOS/other
5.4
13.3
26
49
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
5.4
13.3
26
49
SPAT1197
SPAT
Extensive health check-up of expecting family
0.4
13.0
70
1600
ICB06, ,
NOMESCO Finland
5.3
13.0
26
50
SPAT1241
SPAT
Extensive assessment of psychosocial situation
3.5
12.9
44
129
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.1
12.8
138
716
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.5
12.8
81
336
Q79.6
ICD-10 Finland
Ehlers-Danlos syndrome
14.2
12.8
21
15
P86
ICPC
Anorexia nervosa/bulimia
5.8
12.8
23
40
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.2
12.8
108
510
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
5.0
12.7
27
55
F80.0
ICD-10 Finland
Specific speech articulation disorder
15.6
12.6
20
13
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.0
12.6
22
37
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.5
12.6
111
2101
SPAT1301
SPAT
No procedures
1.7
12.6
333
2276
N06BA02
ATC
dexamfetamine; oral
11.2
12.6
23
21
F10.20
ICD-10 Finland
Alcohol dependence currently independent
5.0
12.2
26
53
OAA43, ,
SPAT
3.0
12.2
54
186
R32
ICD-10 Finland
Unspecified urinary incontinence
5.6
12.1
23
42
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
12.1
149
810
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
4.2
12.1
32
78
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
12.1
98
455
F50.2
ICD-10 Finland
Bulimia nervosa
5.3
12.0
24
46
K03.66
ICD-10 Finland
Tooth plaque
2.1
12.0
126
648
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
12.0
81
347
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
10.7
11.8
22
21
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.2
11.6
45
143
SPAT1379
SPAT
Health check-up of pregnant person
0.4
11.6
61
1413
N02BF02
ATC
pregabalin; oral
2.9
11.5
56
203
N06AA12
ATC
doxepin; systemic
4.0
11.5
32
81
N05AE05
ATC
lurasidone; oral
9.4
11.5
23
25
Z06
ICPC
Unemployment problem
5.1
11.5
24
48
SPAT1312
SPAT
General health counselling
1.6
11.5
452
3382
R4120
NOMESCO Finland
Occupational therapy
2.6
11.4
65
256
R4110, ,
SPAT
2.6
11.4
64
251
RT150, ,
NOMESCO Finland
12.0
11.4
20
17
RT420, ,
NOMESCO Finland
15.2
11.3
18
12
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
35.4
11.3
14
*
N05CD07
ATC
temazepam; oral
3.5
11.2
38
111
P27
ICPC
Fear of mental disorder
3.5
11.2
38
111
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
20.3
11.1
16
8
SPAT1058
SPAT
PEF monitoring instruction
2.4
11.1
79
346
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
11.3
11.1
20
18
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
4.7
11.0
25
54
C07AB07
ATC
bisoprolol; oral
1.8
10.9
185
1113
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.5
10.9
68
280
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.4
10.8
74
1547
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
8.4
10.8
23
28
P28
ICPC
Limited function/disability (P)
5.2
10.8
22
43
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
3.6
10.8
35
99
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
4.4
10.8
27
63
R53
ICD-10 Finland
Malaise and fatigue
1.7
10.8
249
1634
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
9.7
10.8
21
22
F60.1
ICD-10 Finland
Schizoid personality disorder
18.0
10.7
16
9
OAA80, ,
SPAT
0.3
10.7
30
939
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
8.1
10.6
23
29
Z50.5
ICD-10 Finland
Speech therapy
4.1
10.5
29
73
IHZ04, ,
SPAT
3.9
10.5
31
82
A06AD11
ATC
lactulose; oral
2.4
10.5
74
323
A01
ICPC
Pain general/multiple sites
2.2
10.5
87
408
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.4
10.4
58
1317
F84.1
ICD-10 Finland
Atypical autism
111.0
10.4
11
*
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.0
10.3
115
603
N03AF02
ATC
oxcarbazepine; oral
3.0
10.3
46
159
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
10.3
251
1667
SPAT1246
SPAT
Screening of depression or other psychiatric problem
2.1
10.3
102
512
A02BC02
ATC
pantoprazole; systemic
1.5
10.3
466
3571
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
4.5
10.3
25
57
F40.00
ICD-10 Finland
Agoraphobia without concomitant panic disorder
8.9
10.3
21
24
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.9
10.3
47
165
F31.8
ICD-10 Finland
Other bipolar affective disorders
3.0
10.2
44
149
F51.0
ICD-10 Finland
Nonorganic insomnia
1.7
10.2
205
1294
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
10.2
195
1214
N05AE03
ATC
sertindole; oral
13.3
10.2
17
13
N03AX12
ATC
[U] gabapentin; oral
2.1
10.2
101
508
F22.0
ICD-10 Finland
Delusional disorder
8.0
10.1
22
28
ZXY03
NOMESCO Finland
Occupational therapist
8.0
10.1
22
28
ZYC02
NOMESCO Finland
Remote contact by video link
8.5
10.1
21
25
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
10.1
519
4082
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
10.2
10.0
19
19
A04
ICPC
Weakness/tiredness general
1.7
10.0
206
1308
IAA01, ,
SPAT
4.0
9.9
28
72
P72
ICPC
Schizophrenia
3.5
9.8
33
96
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.5
9.8
83
1607
OAB48, ,
SPAT
0.5
9.8
79
1556
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.7
9.6
53
206
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
9.2
9.5
19
21
K59.0
ICD-10 Finland
Constipation
2.5
9.5
57
231
Z00.0
ICD-10 Finland
General medical examination
1.6
9.5
234
1558
U04
ICPC
Incontinence urine
3.9
9.4
27
70
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
9.4
9
*
SPAT1053
SPAT
Memory test
4.9
9.3
20
41
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.3
9.3
71
321
N05AX16
ATC
brexpiprazole; oral
8.8
9.3
19
22
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
13.8
9.2
15
11
R4130
NOMESCO Finland
Speech therapy
4.0
9.1
25
63
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
4.8
9.1
20
42
R4140
NOMESCO Finland
Psychotherapy
4.8
9.1
20
42
P23
ICPC
Adolescent behaviour sympt/compl
3.4
9.1
32
96
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
11.6
9.1
16
14
H03AA01
ATC
levothyroxine sodium; systemic
1.8
9.1
148
879
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
7.1
9.0
21
30
SPAT1216
SPAT
Assessment of functional ability
2.1
9.0
84
412
MA3AE
NOMESCO Finland
Combined first trimester screening
0.3
9.0
20
713
Z02.7
ICD-10 Finland
Issue of medical certificate
2.1
9.0
82
399
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.3
9.0
68
307
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.3
8.9
22
739
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
12.7
8.9
15
12
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.5
8.8
102
1787
X78
ICD-10 Finland
Intentional self-harm by sharp object
3.9
8.7
25
65
SPAT1097
SPAT
Recording of ECG
2.2
8.7
70
324
OAB72, ,
SPAT
3.5
8.7
29
84
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.4
8.6
39
971
OAA11, ,
SPAT
0.3
8.6
25
769
SPAT1380
SPAT
Postpartum check-up
0.4
8.6
52
1144
SPAT1377
SPAT
Polysomnography
3.3
8.5
31
95
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
27.7
8.5
11
*
OAB38, ,
SPAT
2.0
8.5
88
450
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
8.4
77
375
R00.0
ICD-10 Finland
Tachycardia, unspecified
2.6
8.4
49
196
IEP02
NOMESCO Finland
Child-centred family therapy
4.5
8.4
20
45
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
+∞
8.3
8
*
Z2221
NOMESCO Finland
Medical doctor
1.6
8.3
246
1705
F95.9
ICD-10 Finland
Tic disorder, unspecified
10.8
8.3
15
14
OAB76, ,
SPAT
2.8
8.3
41
151
OAA68, ,
SPAT
4.3
8.2
21
50
F61
ICD-10 Finland
Mixed and other personality disorders
14.6
8.2
13
9
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
14.6
8.2
13
9
T07
ICPC
Weight gain
3.0
8.1
34
114
OAB95, ,
SPAT
0.3
8.1
28
789
Z72.9
ICD-10 Finland
Problem related to lifestyle, unspecified
33.6
8.1
10
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
8.1
69
328
Z03
ICPC
Housing/neighbourhood problem
10.1
8.0
15
15
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
6.3
8.0
20
32
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
22.2
8.0
11
5
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.7
8.0
147
904
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
7.9
419
3268
A13
ICPC
Concern/fear medical treatment
4.5
7.9
19
43
T08
ICPC
Weight loss
3.2
7.9
31
100
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.5
7.8
68
1313
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
10.9
7.8
14
13
IEP01
NOMESCO Finland
Psychoeducation, family
7.0
7.8
18
26
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.4
7.8
51
216
P20
ICPC
Memory disturbance
4.4
7.7
19
44
R06.0
ICD-10 Finland
Dyspnoea
1.6
7.7
173
1121
R63.4
ICD-10 Finland
Abnormal weight loss
3.0
7.7
32
107
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
7.6
153
962
N05AL05
ATC
amisulpride; oral
18.5
7.6
11
6
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.3
7.6
56
250
RS140, ,
NOMESCO Finland
6.8
7.6
18
27
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.6
7.6
24
67
SAA02
NOMESCO Finland
Basic examination of mouth
1.6
7.6
911
8250
F91.9
ICD-10 Finland
Conduct disorder, unspecified
10.1
7.5
14
14
OAA12, ,
SPAT
0.2
7.5
12
521
E03.89
ICD-10 Finland
Other specified hypothyroidism
3.1
7.5
31
103
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
7.5
412
3228
WZA10, ,
SPAT
2.2
7.5
60
278
R42
ICD-10 Finland
Dizziness and giddiness
1.7
7.4
139
858
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
13.5
7.4
12
9
F91.3
ICD-10 Finland
Oppositional defiant disorder
13.5
7.4
12
9
N02BF01
ATC
gabapentin; oral
2.3
7.4
53
234
T83
ICPC
Overweight
3.1
7.4
30
99
L28
ICPC
Limited function/disability (L)
2.0
7.3
79
410
XA820, ,
NOMESCO Finland
6.9
7.3
17
25
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
10.9
7.3
13
12
F84.4
ICD-10 Finland
Overactive disorder associated with mental retardation and stereotyped movements
+∞
7.3
7
*
N05AF05
ATC
zuclopenthixol; systemic
9.4
7.3
14
15
H13
ICPC
Plugged feeling ear
1.7
7.3
129
784
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
2.5
7.3
46
192
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
6.3
7.3
18
29
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.6
7.2
42
168
C09CA06
ATC
candesartan; oral
1.8
7.2
119
708
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
4.3
7.2
18
42
R96
ICPC
Asthma
2.0
7.2
80
420
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
3.5
7.1
24
70
H52.1
ICD-10 Finland
Myopia
2.1
7.1
66
324
G47.9
ICD-10 Finland
Sleep disorder, unspecified
2.7
7.1
37
140
ZXY61
NOMESCO Finland
2-person team, special workers
8.0
7.1
15
19
Z91.5
ICD-10 Finland
Personal history of self-harm
8.0
7.1
15
19
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.9
7.1
96
538
F41.01
ICD-10 Finland
Severe panic disorder
3.8
7.1
21
56
RS220, ,
NOMESCO Finland
3.8
7.1
21
56
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.1
7.0
28
91
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
3.1
7.0
28
91
IHZ07, ,
SPAT
7.0
7.0
16
23
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
0.4
7.0
34
820
GD1AA, ,
SPAT
0.4
7.0
39
887
G03DC03
ATC
lynestrenol; oral
3.0
7.0
29
97
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.7
6.9
552
6448
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.7
6.9
118
710
ZYC01, ,
SPAT
1.6
6.9
180
1208
F94.0
ICD-10 Finland
Elective mutism
13.9
6.9
11
8
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
6.9
791
8697
R02
ICPC
Shortness of breath/dyspnoea
1.8
6.9
104
604
N89
ICPC
Migraine
1.9
6.9
79
420
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
6.8
269
1972
WZC00, ,
SPAT
1.6
6.8
150
965
F45.0
ICD-10 Finland
Somatization disorder
8.3
6.8
14
17
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.1
6.8
64
316
G40.89
ICD-10 Finland
Other epilepsy
11.0
6.8
12
11
G47.2
ICD-10 Finland
Disorders of the sleep-wake schedule
9.4
6.8
13
14
Z10.0
ICD-10 Finland
Occupational health examination
0.4
6.8
37
850
F41.00
ICD-10 Finland
Moderate panic disorder
2.7
6.8
36
138
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
4.3
6.8
17
40
F93.2
ICD-10 Finland
Social anxiety disorder of childhood
40.3
6.8
8
*
F40.2
ICD-10 Finland
Specific (isolated) phobias
3.5
6.7
22
63
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.8
6.7
105
616
ICB07, ,
NOMESCO Finland
22.7
6.7
9
*
IAB05
NOMESCO Finland
Psychiatric consultation for gender identity assessment
22.7
6.7
9
*
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
4.0
6.6
18
45
F50.3
ICD-10 Finland
Atypical bulimia nervosa
5.5
6.6
18
33
R45.1
ICD-10 Finland
Restlessness and agitation
12.3
6.6
11
9
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
3.5
6.6
22
64
ZXE22
NOMESCO Finland
Procedure duration at least 4 but less than 5 hours
8.8
6.6
13
15
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
3.8
6.5
19
50
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.8
6.5
19
50
A03FA02
ATC
cisapride; oral, rectal
2.4
6.5
44
189
ZYB05
NOMESCO Finland
Outreach service at patient’s workplace, school or occupational/school health care
10.1
6.5
12
12
IBA01, ,
SPAT
2.8
6.5
31
112
WZA00, ,
SPAT
2.2
6.5
53
248
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
6.5
166
1109
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
3.0
6.5
28
96
UKC02
NOMESCO Finland
Cystoscopy
2.1
6.5
57
275
S22
ICPC
Nail symptom/complaint
2.0
6.4
64
323
R55
ICD-10 Finland
Syncope and collapse
1.9
6.4
75
401
OAA67, ,
SPAT
0.5
6.4
71
1269
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.4
6.4
43
185
XG466
NOMESCO Finland
Sleep oxymetry
3.8
6.4
19
51
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
3.8
6.4
19
51
R1250, ,
SPAT
2.3
6.3
44
192
B02AA02
ATC
tranexamic acid; systemic
1.8
6.3
96
558
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
11.1
6.3
11
10
N03AX14
ATC
levetiracetam; systemic
3.0
6.3
27
92
N03AG04
ATC
vigabatrin; oral
18.1
6.3
9
5
G24.9
ICD-10 Finland
Dystonia, unspecified
18.1
6.3
9
5
F64.8
ICD-10 Finland
Other gender identity disorders
18.1
6.3
9
5
F33.31
ICD-10 Finland
Recurrent depression, severe episode of somatic syndrome
18.1
6.3
9
5
2990A
ICD-9 Finland
Psychoses with origin specific to childhood, Infantile autism[AUTISMUS INFANTILIS,TÄYDELLINEN OIREYHTYMÄ]
+∞
6.3
6
*
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.8
6.3
30
109
181
Kela drug reimbursment
Retigabine and vigabatrin
26.8
6.2
8
*
R46.8
ICD-10 Finland
Other symptoms and signs involving appearance and behaviour
26.8
6.2
8
*
H02
ICPC
Hearing complaint
2.1
6.2
57
280
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
5.4
6.2
17
32
G04BD08
ATC
solifenacin; oral
3.3
6.2
22
67
Z00.8
ICD-10 Finland
Other general examinations
1.8
6.1
99
586
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
7.7
6.1
13
17
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
0.3
6.1
19
564
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
6.1
356
2797
SPAT1153
SPAT
Removal of sutures
1.5
6.1
179
1232
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.1
6.1
25
83
RT130, ,
NOMESCO Finland
12.6
6.1
10
8
IHZ04
NOMESCO Finland
Psychosocial counselling and guidance
12.6
6.1
10
8
R00.2
ICD-10 Finland
Palpitations
1.9
6.1
80
445
R04
ICPC
Breathing problem other
2.5
6.1
37
152
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
8.7
6.1
12
14
R52.9
ICD-10 Finland
Pain, unspecified
1.8
6.1
90
520
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
2.3
6.0
46
209
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
6.7
6.0
14
21
P73
ICPC
Affective psychosis
10.1
6.0
11
11
ZYA02
NOMESCO Finland
Contact at day ward in specialised medical care or in other intensive outpatient care setting
10.1
6.0
11
11
IAZ99
NOMESCO Finland
Other psychiatric consultation
6.1
6.0
15
25

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
230
690
3.93
67.00
1.7
1.6
1164.06
1123.02
nmol/l
0.28
180
530
73
88
8.80
56.67
2.7
2.9
38957.53
42287.50
ug/l
0.95
73
88
194
579
3.84
56.37
1.9
3.2
—
—
—
0
0
261
969
3.21
53.74
1.6
1.5
405.77
25086334.11
pmol/l
1.07
220
873
920
6532
3.27
53.43
4.8
3.6
14.47
14.46
pmol/l
0.06
839
5941
494
2593
2.62
52.72
4.3
6.5
1.22
1.22
mmol/l
1.07
441
2419
414
2003
2.69
52.04
1.8
1.5
97.54
98.05
pmol/l
0.08
246
1124
529
2889
2.57
51.70
5.0
6.6
1.22
1.22
mmol/l
0.59
434
2508
302
1254
2.93
50.77
2.9
2.3
—
—
—
0
0
387
1875
2.62
47.79
2.1
2.7
2.36
2.36
mmol/l
0.24
343
1713
269
1094
2.92
46.57
1.5
1.3
18.30
19.11
nmol/l
0.42
241
979
246
955
3.02
46.30
2.1
3.1
—
—
—
0
0
985
7560
3.48
44.36
5.8
4.1
1.85
1.78
mu/l
1.40
927
7132
517
2956
2.39
43.68
2.6
2.4
65.91
68.56
nmol/l
1.47
482
2795
1002
7835
3.61
42.34
10.6
8.5
139.76
139.51
mmol/l
3.50
961
7562
1001
7859
3.54
41.22
10.6
8.5
3.85
3.90
mmol/l
7.84
957
7554
907
6769
2.77
40.66
4.1
2.6
5.55
5.51
mmol/l
0.34
835
6311
751
5146
2.39
40.45
5.9
6.2
82.18
78.99
u/l
0.82
679
4857
75
144
5.51
37.61
6.5
5.7
401.97
359.89
umol/l
1.46
66
131
247
1121
2.54
33.41
1.9
2.3
—
—
—
0
0
138
460
3.28
33.10
3.2
3.0
—
—
—
0
0
342
1919
2.13
27.44
2.9
3.6
8.60
9.23
mmol/l
1.02
290
1753
183
801
2.54
26.25
2.0
2.0
343.50
382.04
nmol/l
2.09
175
746
424
2621
1.99
25.78
3.3
3.4
29.38
30.72
u/l
0.35
400
2487
600
4187
1.93
25.34
3.3
2.3
—
—
—
0
0
318
1792
2.08
24.85
2.1
2.3
2.70
2.58
mg/l
0.59
264
1566
785
6044
1.99
24.19
3.9
2.9
35.64
32.40
u/l
0.76
741
5815
252
1341
2.13
22.65
2.0
2.2
—
—
—
0
0
332
1965
1.98
22.25
2.6
2.7
55.03
56.00
u/l
0.22
293
1834
383
2405
1.90
21.36
4.5
5.4
38.66
38.09
g/l
1.34
341
2250
29
37
8.02
21.35
1.8
2.2
17.12
14.31
umol/l
0.46
29
37
261
1438
2.06
21.25
2.0
2.2
—
—
—
0
0
278
1572
2.02
21.05
2.7
3.7
7.38
7.40
ph
0.73
64
312
260
1447
2.04
20.52
2.0
2.2
—
—
—
0
0
260
1450
2.03
20.39
2.0
2.2
—
—
—
0
0
1020
8898
2.61
19.81
9.3
7.4
30.23
28.21
u/l
1.62
981
8615
30
44
6.98
19.59
4.4
3.5
234.06
219.14
umol/l
0.06
17
21
261
1485
1.99
19.22
2.5
2.0
290.83
293.91
u/l
0.01
249
1420
42
1467
0.26
18.84
1.2
1.2
—
—
—
0
0
458
3148
1.77
18.37
4.3
5.5
10.21
11.96
umol/l
2.06
409
2938
52
135
3.99
18.03
1.9
2.2
—
—
—
0
0
717
5616
1.77
17.94
3.9
3.4
7.55
7.22
mm/h
0.41
645
5224
66
209
3.29
17.07
1.7
1.6
—
—
—
0
0
743
5946
1.74
16.52
4.1
3.3
36.21
36.65
mmol/mol
0.56
670
5659
537
3965
1.68
15.89
4.1
4.5
6.05
6.21
mmol/l
0.81
489
3556
242
1429
1.88
15.62
2.1
2.1
—
—
—
0
0
149
754
2.13
14.85
1.9
1.7
401.71
304.03
mu/l
1.76
121
668
118
2286
0.46
14.59
1.5
1.6
—
—
—
0
0
114
549
2.20
12.84
3.3
5.4
5.24
5.07
kpa
1.44
106
522
75
302
2.59
12.60
1.3
1.3
—
—
—
0
0
113
548
2.18
12.50
3.3
5.4
7.41
7.40
ph
0.29
12
40
92
413
2.34
12.24
2.8
3.9
1.22
1.22
mmol/l
0.79
74
360
308
2082
1.66
12.06
6.1
5.7
1.06
1.06
inr
0.01
132
753
397
2873
1.59
11.72
1.5
1.4
1.65
1.69
u/ml
0.01
96
702
613
4898
1.55
11.66
10.9
8.6
3.75
3.86
e9/l
0.76
545
4247
533
4130
1.55
11.63
7.6
7.0
—
—
—
0
0
23
873
0.25
11.57
1.3
1.4
—
—
—
0
0
109
544
2.11
11.20
2.7
3.4
5.18
4.83
pmol/l
1.38
93
495
515
3990
1.54
11.06
9.4
8.1
0.00
0.00
e9/l
0.22
432
3208
549
4356
1.51
10.28
3.0
2.8
65.22
71.31
ug/l
0.59
490
4128
112
583
2.02
10.28
2.9
3.4
0.24
0.23
g/l
0.71
98
546
1015
9294
1.97
10.17
11.1
7.8
—
—
—
0
0
145
827
1.87
10.17
2.1
2.2
9.91
12.91
nmol/l
3.07
122
772
41
135
3.11
10.01
1.5
4.3
33.85
35.11
umol/l
0.17
34
130
294
4025
0.63
9.93
2.3
2.2
—
—
—
0
0
36
111
3.32
9.78
2.1
2.5
19.34
17.88
%
1.60
17
52
47
170
2.84
9.75
1.4
1.4
13.22
12.61
u/l
0.04
34
151
150
879
1.82
9.63
4.5
7.6
1.14
1.17
mmol/l
0.57
140
830
231
1535
1.64
9.40
1.7
1.6
1.48
1.43
mmol/l
0.22
200
1389
557
4485
1.48
9.39
7.4
7.0
0.18
0.19
e9/l
0.85
494
3985
825
7209
1.55
9.20
3.6
2.8
4.59
4.62
mmol/l
0.33
768
6901
540
4344
1.47
9.01
7.1
6.6
0.04
0.04
e9/l
0.15
476
3801
255
1752
1.59
9.01
2.7
2.3
13.60
201.04
ng/l
0.58
112
658
539
4340
1.47
8.92
7.0
6.6
0.52
0.54
e9/l
1.96
478
3796
134
783
1.81
8.67
1.9
2.4
2.37
2.40
mmol/l
2.03
114
672
179
2681
0.60
8.63
2.1
1.8
—
—
—
0
0
561
4575
1.45
8.56
6.9
6.5
2.10
2.06
e9/l
0.65
508
4102
10
529
0.18
8.44
1.4
1.4
—
—
—
0
0
786
6849
1.49
8.42
3.2
2.6
1.36
1.22
mmol/l
3.93
722
6521
10
526
0.18
8.37
1.4
1.4
—
—
—
0
0
11
539
0.20
8.29
1.5
1.5
—
—
—
0
0
818
7213
1.49
8.03
3.7
2.9
2.87
2.83
mmol/l
0.69
759
6848
19
30
6.42
7.73
2.0
2.6
—
—
—
0
0
38
140
2.77
7.67
2.2
3.2
—
—
—
0
0
29
93
3.17
7.44
1.4
4.6
—
—
—
0
0
809
7162
1.46
7.40
3.5
2.8
1.32
1.40
mmol/l
7.86
753
6830
774
8567
0.69
7.30
14.1
10.8
334.94
335.29
g/l
0.48
766
8492
143
894
1.69
7.28
4.5
5.4
0.83
0.82
mmol/l
0.71
136
851
146
918
1.68
7.28
1.8
2.3
15.12
15.25
umol/l
0.07
136
864
21
634
0.32
6.97
1.2
1.5
—
—
—
0
0
134
833
1.69
6.97
1.8
2.3
2.56
2.53
g/l
0.34
120
773
280
2063
1.48
6.96
2.9
2.9
0.00
0.00
estimate
1.08
118
822
34
816
0.40
6.91
1.3
1.3
—
—
—
0
0
37
145
2.60
6.66
3.1
4.1
2.12
2.24
mmol/l
0.09
24
81
222
2997
0.68
6.24
1.7
1.7
—
—
—
0
0
246
1802
1.47
6.22
2.8
2.8
1.02
1.02
kg/l
0.58
21
266
503
4184
1.37
6.08
7.6
6.8
7.84
8.10
%
1.24
469
3970
499
4149
1.37
6.04
7.3
6.6
2.67
2.89
%
1.46
465
3930
72
388
1.91
6.03
3.0
2.7
—
—
—
0
0
95
561
1.76
5.94
5.8
4.5
0.00
0.05
%
1.29
28
138
325
2528
1.40
5.88
1.5
1.5
1.92
2.00
g/l
0.59
175
1556
180
1251
1.52
5.87
1.3
1.2
24.55
18.48
iu/ml
0.27
29
336
79
443
1.84
5.86
3.9
5.5
—
—
—
0
0
119
753
1.65
5.78
1.7
2.4
24.74
24.82
%
0.02
100
670
22
71
3.14
5.63
2.4
1.6
91.11
91.80
%
0.31
22
71
188
1330
1.50
5.63
2.2
2.5
560.76
586.10
mosm/kgh2o
0.56
166
1169
96
579
1.72
5.59
5.9
4.5
0.00
0.04
%
1.24
29
160
516
4351
1.34
5.54
7.2
6.3
53.86
54.18
%
0.27
482
4143
98
596
1.71
5.54
5.8
4.5
0.48
0.72
%
0.63
31
177
478
3991
1.34
5.46
7.6
6.7
0.66
0.65
%
0.16
443
3775
521
4429
1.33
5.18
7.3
6.4
32.11
31.70
%
0.41
488
4226
92
564
1.69
5.06
4.5
4.1
0.13
0.50
%
2.91
31
160
95
588
1.67
5.04
1.6
1.7
7.90
7.01
u/l
0.37
79
468
167
1190
1.47
4.80
1.3
1.4
351.30
493.54
titre
0.77
23
192
154
1080
1.49
4.79
3.6
4.4
5.27
14.33
mg/mmol
2.42
90
798
39
184
2.16
4.74
1.5
1.6
—
—
—
0
0
268
2092
1.37
4.60
6.1
6.8
—
—
—
0
0
23
86
2.71
4.60
1.0
1.1
—
—
—
0
0
148
1039
1.49
4.58
3.0
3.7
37.14
211.09
mg/l
1.25
89
770
942
8837
1.41
4.30
10.0
9.0
17.74
20.66
mg/l
2.20
640
6457
251
3137
0.74
4.13
1.6
1.7
—
—
—
0
0
125
867
1.50
4.11
1.2
1.2
59.91
142.10
iu/ml
4.93
45
327
1068
10301
1.76
4.10
17.6
12.9
267.62
259.20
e9/l
4.29
1030
10005
114
779
1.52
4.03
2.6
3.2
—
—
—
0
0
65
387
1.72
4.02
3.9
6.0
9.58
9.64
kpa
0.09
59
371
25
106
2.39
3.92
1.3
1.4
0.92
1.40
promille
0.80
15
81
1068
10314
1.74
3.89
17.4
12.8
29.57
29.71
pg
1.71
1042
10177
1068
10316
1.73
3.86
17.5
12.8
88.04
88.36
fl
1.42
1042
10178
62
369
1.72
3.85
1.5
1.3
—
—
—
0
0
1068
10318
1.73
3.83
17.5
12.9
4.74
4.69
e12/l
2.61
1031
10007
9
15
6.04
3.82
5.7
12.0
—
—
—
0
0
1066
10299
1.70
3.75
17.5
13.0
41.22
41.62
%
0.39
983
9847
1068
10325
1.71
3.72
17.6
13.0
139.47
138.83
g/l
0.79
1042
10185
13
357
0.36
3.66
1.2
1.2
—
—
—
0
0
255
2043
1.32
3.61
2.7
2.9
125.70
53.15
e6/l
0.35
201
1538
28
130
2.18
3.60
1.6
1.6
—
—
—
0
0
81
1208
0.64
3.59
1.5
1.5
—
—
—
0
0
1067
10327
1.68
3.51
17.7
12.9
6.70
6.70
e9/l
0.00
1029
10016
72
458
1.61
3.50
1.2
1.2
—
—
—
0
0
59
357
1.69
3.48
3.2
5.6
53.55
67.37
ng/l
1.89
51
337
15
53
2.85
3.36
1.2
1.2
—
—
—
0
0
46
263
1.78
3.31
1.7
1.6
0.30
0.38
nmol/l
0.59
39
222
33
169
1.98
3.31
1.7
2.6
156.12
214.21
ug/l
0.43
26
155
10
294
0.33
3.27
1.2
1.1
—
—
—
0
0
106
747
1.46
3.25
1.2
1.2
—
—
—
0
0
10
292
0.34
3.23
1.2
1.1
—
—
—
0
0
12
34
3.56
3.20
1.0
1.2
—
—
—
0
0
10
24
4.19
3.20
1.6
1.2
87.50
81.54
nmol/24h
—
10
24
47
274
1.75
3.18
2.0
2.5
0.05
0.13
e6/l
1.54
47
263
603
5437
1.24
3.09
3.5
3.5
—
—
—
0
0
58
368
1.61
2.89
1.8
3.7
67.29
71.41
e9/l
0.37
42
240
138
1048
1.36
2.79
1.3
1.2
—
—
—
0
0
292
3431
0.80
2.76
2.5
2.6
—
—
—
0
0
97
702
1.42
2.62
3.4
6.4
1.51
1.39
mmol/l
0.16
81
560
173
1372
1.31
2.61
2.0
2.5
6.96
8.33
e6/l
0.47
157
1234
76
526
1.48
2.60
1.2
1.2
—
33.31
—
0
23
197
1594
1.29
2.56
2.3
2.9
142.18
116.02
ug/g
0.36
117
1272
172
1369
1.30
2.53
3.5
3.9
—
—
—
0
0
853
8059
1.24
2.51
14.6
11.2
13.66
14.09
%
0.35
831
7913
149
1165
1.32
2.50
1.3
1.2
6.16
6.64
u/ml
0.04
54
455
41
654
0.61
2.49
1.3
1.3
284.55
244.71
miu/ml
0.15
11
324
6
12
5.02
2.40
1.0
4.3
—
—
—
0
0
105
787
1.37
2.33
2.5
1.6
—
—
—
0
0
176
2146
0.79
2.25
2.3
2.3
—
—
—
0
0
81
586
1.41
2.23
5.0
7.7
104.52
104.73
mmol/l
0.22
81
586
9
29
3.12
2.23
1.4
1.3
129.44
138.41
nmol/l
—
9
29
27
153
1.78
2.09
1.6
1.4
328.73
347.83
ug/g
0.14
11
81
107
820
1.34
2.08
1.7
4.0
5.89
6.91
umol/l
0.48
85
682
0
55
0.00
2.07
0.0
1.1
—
—
—
0
0
547
5006
1.18
2.06
3.7
3.4
207.75
148.63
e6/l
—
8
51
220
1852
1.23
2.04
2.8
2.8
0.26
0.30
e6/l
0.11
168
1370
39
247
1.60
2.03
2.8
3.0
72.00
107.49
ng/l
0.61
33
202
134
1664
0.78
1.99
2.5
2.1
—
—
—
0
0
79
582
1.38
1.98
2.7
4.8
1.46
1.58
%
0.68
65
533
11
45
2.46
1.93
1.0
1.4
31.82
32.27
pg
0.15
11
45
83
620
1.37
1.92
1.7
1.6
10.82
13.81
iu/l
0.69
69
494
49
333
1.49
1.89
1.4
1.7
—
—
—
0
0
25
144
1.75
1.86
1.3
2.5
142.89
136.33
g/l
0.82
19
109
19
100
1.92
1.86
2.7
4.4
—
—
—
0
0
6
17
3.54
1.84
1.2
2.2
—
—
—
0
0
210
1779
1.22
1.84
2.3
2.1
—
—
—
0
0
5
12
4.18
1.82
1.2
1.1
—
—
—
0
0
5
12
4.18
1.82
1.4
1.1
—
—
—
0
0
26
153
1.72
1.81
3.0
5.5
—
—
—
0
0
6
152
0.39
1.77
1.0
1.7
—
—
—
0
0
32
201
1.61
1.75
3.2
6.8
—
—
—
0
0
19
104
1.84
1.68
2.2
5.0
3.73
3.82
mmol/l
0.76
19
104
10
40
2.51
1.66
1.2
1.3
—
24.18
—
0
6
27
424
0.63
1.61
2.0
2.3
—
—
—
0
0
13
63
2.08
1.60
1.5
1.5
—
—
—
0
0
58
424
1.39
1.57
1.8
1.7
32.43
36.44
nmol/l
0.75
58
418
12
57
2.12
1.55
1.1
1.1
—
—
—
0
0
0
42
0.00
1.52
0.0
1.3
—
—
—
0
0
12
231
0.51
1.51
1.4
1.1
—
—
—
0
0
271
3049
0.85
1.49
2.3
2.0
—
—
—
0
0
126
1035
1.24
1.49
2.8
2.5
4.07
3.00
e6/l
0.49
74
529
13
65
2.01
1.49
1.0
1.3
1.49
1.69
mmol/l
0.78
13
60
11
216
0.50
1.48
1.0
1.1
1.42
2.24
u/ml
—
5
102
85
666
1.30
1.47
2.0
2.3
26.11
107.51
u/l
0.58
71
558
7
28
2.51
1.45
3.4
2.8
—
—
—
0
0
102
821
1.27
1.44
2.5
2.5
1.16
1.12
ug/l
0.12
85
751
7
29
2.42
1.39
1.0
1.3
—
—
—
0
0
29
190
1.54
1.38
2.1
2.2
—
—
—
0
0
12
61
1.98
1.33
1.5
1.2
107.98
48.65
u/l
0.25
12
56
71
555
1.30
1.28
1.6
1.8
1.03
1.17
g/l
0.94
61
516
30
203
1.49
1.25
1.0
1.1
—
—
—
0
0
56
425
1.33
1.25
5.7
9.5
1.28
0.42
mmol/l
0.70
38
339
6
25
2.41
1.24
1.2
3.1
2.72
4.10
nmol/l
—
6
25
8
36
2.23
1.24
1.0
1.4
—
—
—
0
0
88
713
1.25
1.21
2.2
2.7
10.15
10.33
g/l
0.21
78
649
13
71
1.84
1.19
1.4
1.3
—
—
—
0
0
82
660
1.26
1.19
1.5
1.5
—
—
—
0
0
6
26
2.31
1.19
2.3
2.3
—
—
—
0
0
24
158
1.53
1.15
1.1
1.7
—
—
—
0
0
20
126
1.60
1.15
1.7
7.8
—
—
—
0
0
17
103
1.66
1.13
1.3
1.3
—
—
—
0
0
7
30
2.34
1.12
1.1
1.2
—
—
—
0
0
11
195
0.56
1.11
1.5
1.7
7.21
7.50
mmol/l
0.30
11
188
266
2400
1.14
1.11
2.4
2.4
—
—
—
0
0
287
2607
1.14
1.08
3.4
3.2
57.80
67.42
e6/l
0.09
213
1671
17
105
1.63
1.06
1.1
2.7
—
—
—
0
0
7
33
2.13
1.05
1.3
1.1
149.86
168.36
mmol/24h
—
7
33
14
82
1.72
1.05
1.9
1.4
510.64
312.27
pmol/l
0.67
14
69
122
1047
1.19
0.99
2.4
2.5
5804.54
5437.33
u/l
0.02
30
405
29
400
0.72
0.98
1.7
1.4
—
—
—
0
0
0
30
0.00
0.97
0.0
1.3
—
5347.30
—
0
20
17
108
1.58
0.97
1.5
1.4
—
—
—
0
0
17
109
1.57
0.94
1.4
1.4
4.68
6.32
g/l
—
10
78
17
109
1.57
0.94
1.4
1.4
2.34
2.85
g/l
—
10
77
17
109
1.57
0.94
1.4
1.4
0.24
0.35
g/l
—
10
78
31
226
1.38
0.93
2.2
5.3
0.65
0.66
%
0.07
31
226
12
70
1.72
0.92
1.3
1.2
—
—
nmol/l
—
0
0
33
245
1.36
0.90
1.6
1.9
2.79
5.21
iu/l
1.67
11
99
6
29
2.07
0.89
1.0
1.8
—
—
—
0
0
30
220
1.37
0.88
1.1
2.4
3.43
3.51
mmol/l
0.34
30
207
24
332
0.72
0.85
2.8
2.9
5.91
5.74
umol/l
0.05
17
258
73
872
0.83
0.84
1.7
1.3
—
—
—
0
0
77
645
1.21
0.83
5.7
8.8
—
—
—
0
0
29
216
1.35
0.79
1.1
1.1
—
—
—
0
0
12
74
1.63
0.78
1.0
1.0
—
—
—
0
0
210
1912
1.12
0.77
2.8
2.7
—
—
—
0
0
14
91
1.55
0.75
1.4
2.2
—
—
—
0
0
112
980
1.16
0.75
2.7
2.8
157.10
900.31
ng/l
2.42
54
482
11
67
1.65
0.75
5.5
12.0
12.45
11.21
mmol/l
0.54
11
56
35
271
1.30
0.75
1.9
1.8
3.62
7.82
ug/l
1.91
29
234
5
24
2.09
0.74
4.4
3.3
80.00
157.12
ug/l
—
5
24
7
39
1.80
0.72
1.4
2.0
3.91
3.85
mmol/l
—
7
39
7
39
1.80
0.72
1.4
2.0
106.14
105.74
mmol/l
—
7
39
11
68
1.62
0.72
5.5
11.8
109.09
105.49
mmol/l
1.00
11
57
24
178
1.36
0.69
1.3
1.7
0.46
0.74
g/l
1.90
15
138
112
1265
0.87
0.68
2.8
2.5
314.58
3214.78
umol/l
2.77
85
1171
414
3923
1.09
0.68
3.8
3.9
0.00
0.00
estimate
0.50
121
852
5
27
1.86
0.68
1.0
1.1
—
1.26
—
0
17
86
744
1.17
0.68
1.3
1.3
171.78
292.65
u/ml
1.63
79
683
12
78
1.54
0.65
1.2
1.2
—
—
—
0
0
414
3933
1.08
0.64
2.9
2.8
0.00
0.00
estimate
0.80
121
842
416
3954
1.08
0.63
2.9
2.8
0.00
0.00
estimate
-0.00
115
821
34
270
1.27
0.63
7.1
10.7
0.67
0.70
%
0.22
34
270
26
199
1.31
0.62
1.3
1.3
—
3.34
—
0
20
232
2496
0.91
0.62
1.8
1.7
—
—
—
0
0
81
705
1.16
0.61
1.1
1.2
—
112.38
—
0
21
9
141
0.64
0.60
1.6
4.1
4.68
7.75
u/ml
—
9
136
36
443
0.81
0.60
1.1
1.1
1.25
3.15
u/ml
1.76
21
276
21
157
1.34
0.59
1.2
1.3
5.45
4.15
u/ml
0.18
11
72
25
193
1.30
0.58
2.9
4.1
51.00
53.66
%
0.64
25
193
30
238
1.27
0.57
1.1
2.4
307.63
416.72
mg/l
2.15
30
225
12
81
1.49
0.57
1.0
1.0
—
—
—
0
0
6
36
1.67
0.56
1.5
2.1
—
—
—
0
0
84
739
1.15
0.56
1.1
1.1
—
—
—
0
0
23
295
0.78
0.55
1.0
1.1
0.53
0.46
u/ml
—
9
105
64
553
1.17
0.54
1.3
1.4
—
—
—
0
0
26
204
1.28
0.54
1.1
2.6
—
—
—
0
0
9
63
1.43
0.52
2.0
2.6
54.67
54.35
%
—
9
57
6
96
0.62
0.52
1.0
1.2
—
—
—
0
0
20
257
0.77
0.49
1.2
1.1
—
11.59
—
0
23
18
136
1.33
0.49
1.1
1.3
0.16
2.93
u/ml
1.67
11
69
12
165
0.72
0.46
4.7
2.9
22.60
23.62
mg/l
—
6
104
13
176
0.74
0.46
2.5
2.2
—
—
—
0
0
5
84
0.59
0.45
1.4
1.2
—
—
—
0
0
26
210
1.24
0.45
2.2
4.5
2.71
6.79
ug/l
1.03
18
152
26
319
0.81
0.45
1.2
1.6
—
—
—
0
0
15
112
1.34
0.44
1.1
1.3
68.08
198.43
pmol/l
5.22
15
112
13
174
0.74
0.43
2.6
2.6
—
—
—
0
0
8
58
1.38
0.41
1.1
1.4
1.79
1.21
nmol/l
—
8
49
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
9.3
—
—
—
0
0
8
60
1.34
0.40
1.4
1.3
72.50
74.85
umol/l
—
8
60
162
1732
0.92
0.40
3.3
2.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
2.2
—
99.58
—
0
19
0
19
0.00
0.39
0.0
4.2
—
16.24
—
0
7
35
409
0.85
0.38
1.2
1.5
205.70
202.24
u/ml
—
10
234
12
159
0.75
0.38
1.1
1.3
—
—
—
0
0
62
553
1.13
0.38
1.3
1.2
—
—
—
0
0
23
188
1.23
0.37
3.0
4.0
3.29
3.68
e9/l
0.60
23
188
39
449
0.86
0.36
1.9
1.9
0.49
0.55
ug/l
0.28
22
173
5
78
0.64
0.35
1.2
1.2
—
—
—
0
0
40
348
1.15
0.35
2.1
4.5
21.00
21.55
s
0.17
35
307
41
468
0.87
0.34
1.1
1.1
4.27
7.99
u/ml
0.83
25
303
22
181
1.22
0.34
4.5
2.9
—
—
—
0
0
26
218
1.20
0.34
9.3
12.1
—
—
—
0
0
104
961
1.09
0.34
1.7
1.6
—
—
—
0
0
32
371
0.86
0.33
1.1
1.1
—
—
—
0
0
113
1051
1.08
0.32
2.9
2.4
1.15
0.99
e6/l
0.13
61
544
40
454
0.88
0.32
1.1
1.1
0.68
1.07
u/ml
0.37
20
245
7
52
1.35
0.31
1.0
1.1
200.57
223.27
iu/ml
—
7
52
20
240
0.83
0.31
1.1
1.1
—
—
—
0
0
13
164
0.79
0.31
1.2
1.1
—
—
—
0
0
7
53
1.32
0.31
1.7
1.6
7.74
5.75
mmol/l
—
7
43
7
57
1.23
0.29
63.0
34.0
7.46
7.15
ug/l
—
7
51
14
112
1.25
0.28
1.0
1.0
—
—
—
0
0
18
149
1.21
0.28
2.5
2.7
68.61
28.25
mu/l
0.55
13
138
24
279
0.86
0.27
1.0
1.2
—
—
—
0
0
9
73
1.23
0.25
1.9
1.5
10.94
9.58
umol/l
—
9
68
184
1760
1.05
0.25
3.5
4.7
96.19
92.75
%
1.16
172
1725
46
506
0.91
0.24
1.2
1.2
2.83
2.81
u/ml
0.00
26
302
342
3327
1.04
0.23
2.9
2.6
6.36
5.96
ph
0.97
14
374
7
95
0.74
0.22
1.3
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
2.1
—
360.50
—
0
6
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
—
—
0
0
8
103
0.78
0.21
1.6
1.1
—
—
—
0
0
187
1941
0.96
0.21
1.7
1.7
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
89
841
1.06
0.19
2.1
2.0
—
—
—
0
0
6
52
1.15
0.19
5.0
3.3
370.33
550.06
u/ml
—
6
52
79
835
0.94
0.18
1.2
1.4
—
—
—
0
0
26
233
1.12
0.17
1.0
1.1
—
—
—
0
0
7
61
1.15
0.17
1.0
1.8
—
—
—
0
0
13
110
1.18
0.17
1.9
2.8
41.92
38.81
%
0.52
13
110
91
955
0.95
0.16
1.6
2.0
—
—
—
0
0
8
68
1.18
0.16
1.0
1.6
5.06
3.20
u/ml
—
8
68
6
80
0.75
0.15
1.0
1.1
—
—
—
0
0
28
307
0.91
0.15
1.2
1.6
102.60
100.45
u/ml
—
5
52
11
93
1.18
0.14
2.1
3.8
—
—
—
0
0
56
529
1.06
0.14
2.1
2.0
3.56
5.01
e9/l
1.34
39
478
12
103
1.17
0.13
1.0
1.1
—
—
—
0
0
8
99
0.81
0.13
1.0
1.0
—
—
—
0
0
31
335
0.92
0.13
1.1
1.1
3.89
6.33
u/ml
0.42
19
191
33
355
0.93
0.12
1.2
1.3
—
—
—
0
0
24
219
1.10
0.12
1.1
2.5
9.58
16.73
e6/l
0.37
19
164
161
1570
1.03
0.11
2.0
2.3
0.66
1.00
mg/l
2.01
101
1056
20
182
1.10
0.11
1.2
1.1
200.00
172.63
iu/ml
—
7
64
13
146
0.89
0.10
1.3
1.2
1.86
5.01
u/ml
—
7
64
5
44
1.14
0.10
24.0
7.3
—
—
—
0
0
6
58
1.03
0.08
2.7
2.1
—
—
—
0
0
5
60
0.83
0.08
13.4
3.9
—
—
—
0
0
5
62
0.81
0.08
1.0
1.1
0.21
15.75
u/ml
—
5
57
8
78
1.03
0.07
1.8
1.6
—
—
—
0
0
7
83
0.84
0.07
2.0
1.6
—
—
—
0
0
10
111
0.90
0.06
1.3
1.1
—
8.12
—
0
23
24
251
0.96
0.04
2.4
2.1
—
—
—
0
0
12
112
1.07
0.03
1.0
3.9
—
—
—
0
0
26
267
0.97
0.01
5.0
4.5
0.46
0.28
g/l
0.35
16
157
26
254
1.02
0.00
1.7
1.9
—
4.67
—
0
6
53
526
1.01
0.00
1.1
1.1
—
—
—
0
0
28
282
0.99
0.00
1.7
1.7
—
—
—
0
0
13
127
1.02
0.00
1.0
1.0
0.32
2.49
u/ml
—
6
50
14
143
0.98
0.00
1.1
1.0
—
—
—
0
0
19
185
1.03
0.00
8.0
6.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
5
51
0.98
0.00
1.0
1.3
1.59
1.48
g/l
—
5
51
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
8.8
—
—
—
0
0
5
51
0.98
0.00
13.4
4.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
1.71
—
0
8
9
99
0.91
-0.00
1.7
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
30
300
1.00
-0.00
1.0
1.1
7.46
8.29
u/ml
0.10
15
150
0
7
0.00
-0.00
0.0
1.0
—
76.94
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
48.29
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
63
0.95
-0.00
3.7
9.0
9.55
9.00
mg/l
—
6
57
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
6
62
0.97
-0.00
2.7
12.6
13.77
12.13
%
—
6
62
0
5
0.00
-0.00
0.0
3.4
—
0.44
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
32.28
—
0
6

Mortality – FinRegistry

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

Index endpoint: F5_AUTISM – Autism

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).